Search Results for 'patients tdf'

patients tdf published presentations and documents on DocSlides.

Selecting an Initial Antiretroviral Therapy (ART) Regimen
Selecting an Initial Antiretroviral Therapy (ART) Regimen
by cappi
www.hivguidelines.org. Purpose of . This Guideline...
HBV resistance and
HBV resistance and
by calandra-battersby
immune escape . mutants. Anders Boyd, MPH, . PhD....
Switch to DRV/r + RAL
Switch to DRV/r + RAL
by debby-jeon
SPARE . Study. SPARE Study: switch to DRV/r + RAL...
NRTI-sparing
NRTI-sparing
by liane-varnes
SPARTAN. PROGRESS. RADAR. NEAT001/ANRS 14. 3. A40...
Comparison of NNRTI vs NNRTI
Comparison of NNRTI vs NNRTI
by tatyana-admore
ENCORE. EFV vs RPV. ECHO-THRIVE. STAR. EFV vs ETR...
Michael S.  Saag , MD  Eric S.
Michael S. Saag , MD Eric S.
by pamella-moone
Daar. , MD. Antiretroviral Therapy:. A Case-Based...
Rajesh T. Gandhi, MD Director, HIV Clinical Services and Education
Rajesh T. Gandhi, MD Director, HIV Clinical Services and Education
by calandra-battersby
Massachusetts General Hospital. Boston, Massachus...
Switching from TDF/FTC to TAF/
Switching from TDF/FTC to TAF/
by fanny
FTC. Study 311-1089. Switching from TDF/FTC to TAF...
Clinical considerations for the
Clinical considerations for the
by helene
introduction . of . DTG. Nandita Sugandhi. ICAP at...
Viral hepatitis Best of ILC 2018
Viral hepatitis Best of ILC 2018
by roberts
About these slides. These slides provide highlight...
Essentials for Optimal Care of HIV Patients
Essentials for Optimal Care of HIV Patients
by marina-yarberry
Evidence-Based Approaches. Simply Speaking. ®. ...
Tenofovir nephrotoxicity in resource limited setting of Western India : Higher rate of renal functi
Tenofovir nephrotoxicity in resource limited setting of Western India : Higher rate of renal functi
by conchita-marotz
A.Dravid. 1. ,A.Sadre. 2. ,S.Dhande. 1. , A.Borka...
Treatment-Experienced Patients in Resource-Limited Settings
Treatment-Experienced Patients in Resource-Limited Settings
by pasty-toler
Susan M. Graham . Assistant Professor, Medicine a...
ID Week 2016: HIV Update
ID Week 2016: HIV Update
by min-jolicoeur
Robert Harrington, M.D.. ID Week 2016: HIV Update...
Innovative Strategies for the Management
Innovative Strategies for the Management
by karlyn-bohler
of HIV Infection. Dual therapies without NRTIs. J...
CROI 2015: What’s New in Hepatitis?
CROI 2015: What’s New in Hepatitis?
by myesha-ticknor
Nina Kim, MD . Associate Professor of Medicine. D...
Les satisfactions : traitements efficaces, robustes, avec u
Les satisfactions : traitements efficaces, robustes, avec u
by phoebe-click
Dr Denis Lacoste. Bordeaux. Les satisfactions : ....
Modifying Therapy in the Treatment-experienced Patient:
Modifying Therapy in the Treatment-experienced Patient:
by yoshiko-marsland
When should it be done?. Professor of Medicine. U...
Antiretroviral Therapy (ART)
Antiretroviral Therapy (ART)
by alexa-scheidler
Dr. S . Ntshalintshali. Ngwelezana. hospital. N...
Comparison of PI vs PI ATV vs ATV/r			 	BMS 089
Comparison of PI vs PI ATV vs ATV/r BMS 089
by phoebe-click
LPV/r mono vs LPV/r ZDV/3TC MONARK. LPV/r QD v...
Joseph J. Eron Jr, MD
Joseph J. Eron Jr, MD
by lois-ondreau
Joseph J. Eron Jr, MD Professor of Medicine Unive...
PrEP to Prevent HIV and Promote Sexual Health
PrEP to Prevent HIV and Promote Sexual Health
by cheryl-pisano
PrEP to Prevent HIV and Promote Sexual Health www...
Kenneth E. Sherman, MD, PhD
Kenneth E. Sherman, MD, PhD
by heavin
Gould Professor of Medicine. Director, Division of...